HLS Therapeutics, Inc. (HLS.TO)
3.84
+0.15
(+4.06%)
CAD |
TSX |
Aug 25, 16:00
HLS Therapeutics Total Liabilities (Quarterly) : 104.01M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 104.01M |
| March 31, 2026 | 101.20M |
| December 31, 2025 | 103.98M |
| September 30, 2025 | 109.21M |
| June 30, 2025 | 112.59M |
| March 31, 2025 | 125.43M |
| December 31, 2024 | 127.37M |
| September 30, 2024 | 124.84M |
| June 30, 2024 | 148.62M |
| March 31, 2024 | 147.08M |
| December 31, 2023 | 146.84M |
| September 30, 2023 | 153.35M |
| June 30, 2023 | 152.68M |
| March 31, 2023 | 155.99M |
| December 31, 2022 | 157.63M |
| September 30, 2022 | 163.36M |
| June 30, 2022 | 157.67M |
| March 31, 2022 | 139.26M |
| December 31, 2021 | 145.48M |
| September 30, 2021 | 150.92M |
| June 30, 2021 | 156.37M |
| March 31, 2021 | 162.48M |
| December 31, 2020 | 171.55M |
| September 30, 2020 | 183.20M |
| June 30, 2020 | 167.88M |
| Date | Value |
|---|---|
| March 31, 2020 | 194.88M |
| December 31, 2019 | 183.45M |
| September 30, 2019 | 178.50M |
| June 30, 2019 | 185.10M |
| March 31, 2019 | 190.86M |
| December 31, 2018 | 202.05M |
| September 30, 2018 | 201.56M |
| June 30, 2018 | 241.42M |
| March 31, 2018 | 252.86M |
| December 31, 2017 | |
| September 30, 2017 | 0.944M |
| June 30, 2017 | 0.723M |
| March 31, 2017 | 0.665M |
| December 31, 2016 | 0.742M |
| September 30, 2016 | 0.70M |
| June 30, 2016 | 0.607M |
| March 31, 2016 | 0.527M |
| December 31, 2015 | 0.794M |
| September 30, 2015 | 0.848M |
| June 30, 2015 | 1.142M |
| March 31, 2015 | 4.767M |
| December 31, 2014 | 15.58M |
| September 30, 2014 | 21.20M |
| June 30, 2014 | 19.00M |
| March 31, 2014 | 14.73M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bausch Health Cos., Inc. | 36.31B |
| Cipher Pharmaceuticals, Inc. | 27.86M |
| BioSyent, Inc. | 14.62M |
| Revive Therapeutics Ltd. | 4.306M |
| Knight Therapeutics, Inc. | 246.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 182.38M |
| Shareholders Equity (Quarterly) | 78.37M |
| Debt to Equity Ratio | 0.7586 |
| Current Ratio | 1.049 |
| Net Debt Paydown Yield | 4.68% |